Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Julphar
Daiichi Sankyo
Federal Trade Commission
Citi
Moodys
Medtronic
McKesson

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMPHETAMINE

« Back to Dashboard

Clinical Trials for Amphetamine

Trial ID Title Status Sponsor Phase Summary
NCT00000305 Amphetamine Cocaine Interaction Study - 2 Terminated National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000305 Amphetamine Cocaine Interaction Study - 2 Terminated University of Texas Phase 1 The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000305 Amphetamine Cocaine Interaction Study - 2 Terminated The University of Texas Health Science Center, Houston Phase 1 The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000308 Dextroamphetamine-Cocaine Behavioral Intervention - 5 Completed University of Texas Phase 2 The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.
NCT00000308 Dextroamphetamine-Cocaine Behavioral Intervention - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.
NCT00000347 Risperidone for Treatment of Cocaine Dependence in Outpatients - 12 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate pharmacological efficacy and clinical safety of risperidone in the treatment of cocaine and amphetamine dependence.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Amphetamine

Condition Name

Condition Name for Amphetamine
Intervention Trials
Attention Deficit Hyperactivity Disorder 12
Healthy 11
Cocaine Dependence 9
Cocaine-Related Disorders 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Amphetamine
Intervention Trials
Attention Deficit Disorder with Hyperactivity 32
Disease 27
Hyperkinesis 24
Cocaine-Related Disorders 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Amphetamine

Trials by Country

Trials by Country for Amphetamine
Location Trials
United States 107
Germany 12
Canada 9
France 6
Switzerland 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Amphetamine
Location Trials
California 14
Texas 14
New York 12
Florida 8
Maryland 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Amphetamine

Clinical Trial Phase

Clinical Trial Phase for Amphetamine
Clinical Trial Phase Trials
Phase 4 30
Phase 3 15
Phase 2/Phase 3 8
[disabled in preview] 59
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Amphetamine
Clinical Trial Phase Trials
Completed 82
Recruiting 22
Not yet recruiting 14
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Amphetamine

Sponsor Name

Sponsor Name for Amphetamine
Sponsor Trials
National Institute on Drug Abuse (NIDA) 24
Shire 11
Yale University 9
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Amphetamine
Sponsor Trials
Other 148
NIH 36
Industry 35
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Moodys
QuintilesIMS
Fish and Richardson
Citi
Chinese Patent Office
UBS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.